Alpha Tau Medical Cash Flow Statement
NASDAQ: DRTSHealth CareMedical/Dental InstrumentsUSD
14.41+0.41 (+2.93%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Alpha Tau Medical free cash flow
In fiscal 2025, Alpha Tau Medical generated -$26.7 million of operating cash flow and spent $6.1 million on capital expenditures. That left free cash flow of -$32.8 million.
Summary generated from market data by MetaCap's automated system. Methodology
Alpha Tau Medical cash flow statement (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 |
|---|---|---|---|---|---|---|---|
| Net Income | -42.63M | -31.75M | -29.16M | -33.76M | 27.27M | 8.88M | 8.46M |
| Net Income growth (YoY) | — | — | — | -223.80% | +207.04% | +4.94% | — |
| Depreciation & Amortization | 1.23M | 1.10M | 1.07M | 979.00K | 776.00K | 86.00K | 66.00K |
| Stock-Based Compensation | 10.62M | 9.92M | 7.93M | 6.75M | 812.00K | 596.00K | 546.00K |
| Change in Working Capital | 316.00K | 407.00K | 1.42M | -121.00K | 396.00K | 397.00K | -361.00K |
| Operating Cash Flow | -26.68M | -19.78M | -17.96M | -23.88M | -11.81M | -7.25M | -6.91M |
| Capital Expenditures | -6.08M | -2.24M | -6.40M | -904.00K | -2.93M | -3.77M | -1.29M |
| Investing Cash Flow | -20.59M | 20.77M | 18.68M | -89.94M | 19.27M | -7.82M | -10.16M |
| Debt Issued | — | — | 5.25M | — | — | — | — |
| Financing Cash Flow | 45.77M | 25.00K | 5.30M | 96.91M | 111.00K | 29.32M | 5.32M |
| Net Change in Cash | -1.52M | 1.07M | 5.97M | -17.17M | 7.68M | 14.33M | -11.77M |
| Free Cash Flow | -32.76M | -22.02M | -24.36M | -24.78M | -14.74M | -11.02M | -8.20M |
This table shows 7 annual periods of Alpha Tau Medical's cash flow statement, from FY 2025 back to FY 2019, across 11 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow DRTS's reporting calendar. What is a cash flow statement?